140 related articles for article (PubMed ID: 16289656)
1. Inhibition of HIV-1 virus replication using small soluble Tat peptides.
Agbottah E; Zhang N; Dadgar S; Pumfery A; Wade JD; Zeng C; Kashanchi F
Virology; 2006 Feb; 345(2):373-89. PubMed ID: 16289656
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
3. Effect of transcription peptide inhibitors on HIV-1 replication.
Van Duyne R; Cardenas J; Easley R; Wu W; Kehn-Hall K; Klase Z; Mendez S; Zeng C; Chen H; Saifuddin M; Kashanchi F
Virology; 2008 Jul; 376(2):308-22. PubMed ID: 18455747
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.
Devadas K; Boykins RA; Hewlett IK; Wood OL; Clouse KA; Yamada KM; Dhawan S
Peptides; 2007 Mar; 28(3):496-504. PubMed ID: 17188401
[TBL] [Abstract][Full Text] [Related]
5. Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain.
Ariumi Y; Kaida A; Hatanaka M; Shimotohno K
Biochem Biophys Res Commun; 2001 Sep; 287(2):556-61. PubMed ID: 11554765
[TBL] [Abstract][Full Text] [Related]
6. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
Liang C; Wainberg MA
AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
[TBL] [Abstract][Full Text] [Related]
7. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
8. Recent status of HIV-1 gene expression inhibitors.
Baba M
Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
[TBL] [Abstract][Full Text] [Related]
9. Small HIV-1-Tat peptides inhibit HIV replication in cultured T-cells.
Löhr M; Kibler KV; Zachary I; Jeang KT; Selwood DL
Biochem Biophys Res Commun; 2003 Jan; 300(2):609-13. PubMed ID: 12504126
[TBL] [Abstract][Full Text] [Related]
10. In vitro phosphorylation of human immunodeficiency virus type 1 Tat protein by protein kinase C: evidence for the phosphorylation of amino acid residue serine-46.
Holmes AM
Arch Biochem Biophys; 1996 Nov; 335(1):8-12. PubMed ID: 8914829
[TBL] [Abstract][Full Text] [Related]
11. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis.
Boykins RA; Mahieux R; Shankavaram UT; Gho YS; Lee SF; Hewlett IK; Wahl LM; Kleinman HK; Brady JN; Yamada KM; Dhawan S
J Immunol; 1999 Jul; 163(1):15-20. PubMed ID: 10384093
[TBL] [Abstract][Full Text] [Related]
13. Homonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein.
Grégoire C; Péloponèse JM; Esquieu D; Opi S; Campbell G; Solomiac M; Lebrun E; Lebreton J; Loret EP
Biopolymers; 2001; 62(6):324-35. PubMed ID: 11857271
[TBL] [Abstract][Full Text] [Related]
14. Insights on HIV-1 Tat:P/CAF bromodomain molecular recognition from in vivo experiments and molecular dynamics simulations.
Pantano S; Marcello A; Ferrari A; Gaudiosi D; Sabò A; Pellegrini V; Beltram F; Giacca M; Carloni P
Proteins; 2006 Mar; 62(4):1062-73. PubMed ID: 16362936
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication by a Tat transdominant negative mutant in human peripheral blood lymphocytes from healthy donors and HIV-1-infected patients.
Rossi C; Balboni PG; Betti M; Marconi PC; Bozzini R; Grossi MP; Barbanti-Brodano G; Caputo A
Gene Ther; 1997 Nov; 4(11):1261-9. PubMed ID: 9425451
[TBL] [Abstract][Full Text] [Related]
16. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.
Noel RJ; Kumar A
Virology; 2006 Mar; 346(1):127-38. PubMed ID: 16313937
[TBL] [Abstract][Full Text] [Related]
17. HIV TAT basic peptide is not a high-affinity ligand for VEGF receptor 2.
Rubio Demirovic A; Canadi J; Weiglhofer W; Scheidegger P; Jaussi R; Kurt BH
Biol Chem; 2003; 384(10-11):1435-41. PubMed ID: 14669986
[TBL] [Abstract][Full Text] [Related]
18. Furin cleavage of the HIV-1 Tat protein.
Tikhonov I; Ruckwardt TJ; Berg S; Hatfield GS; David Pauza C
FEBS Lett; 2004 May; 565(1-3):89-92. PubMed ID: 15135058
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Tat modulates T-bet expression and induces Th1 type of immune response.
Kulkarni A; Ravi DS; Singh K; Rampalli S; Parekh V; Mitra D; Chattopadhyay S
Biochem Biophys Res Commun; 2005 Apr; 329(2):706-12. PubMed ID: 15737643
[TBL] [Abstract][Full Text] [Related]
20. [Molecular mechanisms of action of dendrons, containing 48-60 sequence of HIV-1 TAT-protein, on the functional activity of the adenylyl cyclase signaling systems].
Shpakov AO; Gur'ianov IA; Avdeeva EV; Vorob'ev VI; Vlasov GP
Tsitologiia; 2004; 46(11):1011-22. PubMed ID: 15704884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
